Prognostic Role of <i>FGFR3</i> Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
Background: bladder cancer is one of the most common urinary tract malignancies. Establishment of robust predictors of disease progression and outcome is important for personalizing treatment of non-muscular invasive bladder carcinoma (NMIBC). In this study we evaluated association of PD-L1 expressi...
Main Authors: | Ekaterina Blinova, Anton Buzdin, Dmitry Enikeev, Dmitry Roshchin, Maria Suntsova, Elena Samyshina, Aleksey Drobyshev, Olga Deryabina, Tatiana Demura, Dmitry Blinov, Evgenia Shich, Haydar Barakat, Pieter Borger, Dmitrij Merinov, Aleksandr Kachmazov, Stanislav Serebrianyi, Oxana Tumutolova, Natalia Potoldykova, Pavel Zhdanov, Vagarshak Grigoryan, Dmitrij Perepechin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/10/11/305 |
Similar Items
-
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
by: Ekaterina Blinova, et al.
Published: (2020-05-01) -
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
by: Ekaterina Blinova, et al.
Published: (2021-09-01) -
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
by: Ekaterina Blinova, et al.
Published: (2019-05-01) -
Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
by: Kristina A. Malsagova, et al.
Published: (2020-12-01) -
Twelve-Year Cycle in the Cloud Top Winds Derived from VMC/Venus Express and UVI/Akatsuki Imaging
by: Igor V. Khatuntsev, et al.
Published: (2022-12-01)